This funding opportunity is designed to support crucial research aimed at identifying molecular targets for disorders associated with or induced by pregnancy. The grant’s primary purpose is to encourage the development of novel, safer, and more effective therapeutic medications specifically intended for use during pregnancy. By fostering such innovations, this initiative seeks to significantly advance our understanding and treatment of complex pregnancy-related health conditions, ultimately improving outcomes for both mothers and their babies. This grant is for advancing pharmacology and molecular biology within the critical field of reproductive health, addressing an unmet need for specialized treatments.
Opportunity ID: 247095
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-HD-14-032 |
| Funding Opportunity Title: | Discovery of Molecular Targets for Pregnancy-Related/Induced Diseases and Development of Therapeutics to Prevent/Treat These Diseases (STTR) (R41/R42) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.865 — Child Health and Human Development Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 07, 2013 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Feb 27, 2014 |
| Current Closing Date for Applications: | Feb 27, 2014 |
| Archive Date: | Mar 30, 2014 |
| Estimated Total Program Funding: | $500,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this funding opportunity announcement (FOA) is to encourage grant applications that will identify molecular targets for pregnancy associated/induced disorders and will lead to the development of new safer and more effective medications for use in pregnancy. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-14-032.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.865 | ADOBE-FORMS-B2 | Adobe-Forms-B2 | PKG00189072 | Jan 27, 2014 | Feb 27, 2014 | View |
Package 1
Mandatory forms
247095 RR_SF424_1_2-1.2.pdf
247095 PerformanceSite_1_4-1.4.pdf
247095 RR_OtherProjectInfo_1_3-1.3.pdf
247095 RR_KeyPersonExpanded_1_2-1.2.pdf
247095 RR_Budget-1.1.pdf
247095 RR_SubawardBudget30-1.2.pdf
247095 PHS398_CoverPageSupplement_1_4-1.4.pdf
247095 PHS398_ResearchPlan_1_3-1.3.pdf
247095 PHS398_Checklist_1_3-1.3.pdf
247095 SBIR_STTR_Information_1_1-1.1.pdf
Optional forms
247095 PHS_CoverLetter_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
